期刊文献+

脂联素基因+45和+276多态性与川崎病的关系 被引量:5

Association of +45 and +276 polymorphisms in the adiponectin gene with the development of Kawasaki disease
原文传递
导出
摘要 目的检测川崎病患儿脂联素基因+45T/G、+276G/T多态性分布情况,探讨其与川崎病发病和冠状动脉损伤(CAL)发生的关系。方法采取病例对照研究方法,选取81例川崎病患儿(其中11例并发CAL)和100例正常体检儿童(对照组)。采用基因测序方法测定脂联素基因+45和+276位点的多态性分布。结果川崎病组脂联素基因+45位点基因型TT、TG、GG以及T/G的等位基因频率与对照组比较差异无统计学意义(P>0.05);川崎病组中并发CAL者与无CAL者该位点的基因型分布频率和等位基因频率比较差异亦无统计学意义(P>0.05)。川崎病组与对照组脂联素基因+276位点基因型GG、GT、TT及G/T等位基因频率的比较差异均有统计学意义(P<0.05);GG基因型为川崎病发病的危险因素(OR=2.313,P=0.006)。川崎病患儿中CAL组脂联素基因+276位点基因型分布与非CAL组比较差异无统计学意义(P>0.05)。结论脂联素基因+276位点多态性可能与川崎病的发生相关,但与CAL的发生无关;脂联素基因+45位点多态性可能与川崎病和CAL的发生均无关。 Objective To investigate the distribution of adiponectin +45 T/G and +276 G/T polymorphisms and its association with the development of Kawasaki disease and coronary artery lesion(CAL). Methods A total of 81 children with Kawasaki disease(among whom 11 had CAL) and 100 normal children who underwent physical examination(control group) were enrolled in a case-control study. Sequencing was performed to investigate the distribution of adiponectin +45 T/G and +276 G/T polymorphisms. Results There were no significant differences between the Kawasaki disease and control groups in the frequencies of TT, TG, and GG genotypes and T/G alleles of +45 T/G polymorphism in the adiponectin gene(P〈0.05). In the Kawasaki disease group, there were also no significant differences in the genotype and allele frequencies of the +45 T/G polymorphism between the children with CAL and those without(P〉0.05). There were significant differences between the Kawasaki disease and control groups in the frequencies of GG, GT, and TT genotypes and G/T alleles of +276 G/T polymorphism in the adiponectin gene(P〈0.05). GG genotype was a risk factor for the development of Kawasaki disease(OR=2.313, P=0.006). In the Kawasaki disease group, there was no significant difference in the genotype distribution of the +276 G/T polymorphism between the children with CAL and those without(P〉0.05). Conclusions The adiponectin +276 G/T polymorphism may be associated with the development of Kawasaki disease, but not associated with CAL. The adiponectin +45 T/G polymorphism may not be associated with Kawasaki disease or CAL.
作者 黄秒 董国庆 肖菲 苏月月 李明珠 HUANG Miao;DONG Guo-Qing;XIAO Fei;SU Yue-Yue;LI Ming-Zhu.(Department of Pediatrics, Shenzhen Maternity and Child Health Care Hospital Shenzhen, Guangdong 518028, China)
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2018年第7期549-553,共5页 Chinese Journal of Contemporary Pediatrics
基金 深圳市卫生计生系统科研项目(201501036)
关键词 脂联素 多态性 川崎病 冠状动脉损伤 儿童 Adiponectin Polymorphism Kawasaki disease Coronary artery lesion Child
  • 相关文献

参考文献4

二级参考文献72

  • 1张陆,惠汝太.3’非翻译区在转录后调控中的作用[J].中国分子心脏病学杂志,2005,5(4):619-625. 被引量:1
  • 2胡亚美 江载芳.诸福棠实用儿科学[M].北京:人民卫生出版社,2002.1294.
  • 3Takeshita S, Takabayashi H, Yoshida N. Circulating adiponectin levels in Kawasaki disease[J]. Acta Paediatr, 2006, 95(10): 1312-1314.
  • 4Ayusawa M, Sonobe T, Uemura S, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition)[J]. Pediatr Int, 2005, 47(2): 232-234.
  • 5Scherer PE, Williams S, Fogliano M, et al. A novel serum protein similar to C1q, produced exclusively in adipocytes[J]. J Biol Chem, 1995, 270(45): 26746-26749.
  • 6Furukawa S, Matsubara T, Ichiyama T. Regulation of proinflammatory cytokine cascade in Kawasaki disease[J]. Nihon Rinsho, 2008, 66(2): 258-264.
  • 7Simons PJ, van den Pangaart PS, Aerts JM, et al. Proinflammatory delipidizing cytokines reduce adiponectin secretion from human adipocytes without affecting adiponectin oligomerization[J]. J Endocrinol, 2007, 192: 289-299.
  • 8Iwaki M, Matsuda M, Maeda N, et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors[J]. Diabetes, 2003, 52(7): 1655-1663.
  • 9Ruan Y, Ye B, Zhao X. Clinical characteristics of Kawasaki syndrome and the risk factors for coronary artery lesions in China[J]. Pediatr Infect Dis J, 2013, 32(10): e397-e402.
  • 10Akbiyik F, Ray DM, Gettings KF, et al. Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes[J]. Blood, 2004, 104(5): 1361-1368.

共引文献29

同被引文献32

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部